|
OSBP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.3338000037777E-08 |
| Normal-vs-Stage3 |
4.49029999849415E-08 |
| Normal-vs-Stage4 |
2.96350000095202E-08 |
| Stage1-vs-Stage2 |
5.943400E-01 |
| Stage1-vs-Stage3 |
3.825200E-01 |
| Stage1-vs-Stage4 |
5.520400E-01 |
| Stage2-vs-Stage3 |
8.430800E-01 |
| Stage2-vs-Stage4 |
3.317400E-01 |
| Stage3-vs-Stage4 |
3.258600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
1.32509558881111E-11 |
| Normal-vs-Asian |
1.944190E-03 |
| Caucasian-vs-AfricanAmerican |
2.437000E-01 |
| Caucasian-vs-Asian |
3.571800E-01 |
| AfricanAmerican-vs-Asian |
6.477400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.82140003079923E-09 |
| Male-vs-Female |
1.324200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.01879657224913E-11 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
2.86248802439104E-12 |
| Normal-vs-Extreme_Obese |
1.70808999999661E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.564800E-01 |
| Normal_Weight-vs-Obese |
2.905600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.866400E-01 |
| Extreme_Weight-vs-Obese |
3.377900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
1.744960E-01 |
| Obese-vs-Extreme_Obese |
8.581200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.44289999995484E-06 |
| Normal-vs-Age(41-60Yrs) |
2.8199664825479E-14 |
| Normal-vs-Age(61-80Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(81-100Yrs) |
3.18000004106977E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.340600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.169610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.498300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.920300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.187840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.187800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
1.21770005190314E-09 |
| Normal-VS-KIRP CIMP |
1.022740E-04 |
| Normal-VS-Unclassified PRCC |
5.76470005064778E-09 |
| Type1 PRCC-VS-Type2 PRCC |
4.412100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.297370E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.196570E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.340800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.390800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.881800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.32747196252603E-14 |
| Normal-vs-N1 |
8.57860000036403E-07 |
| Normal-vs-N2 |
1.416790E-04 |
| N0-vs-N1 |
1.100840E-01 |
| N0-vs-N2 |
4.862800E-01 |
| N1-vs-N2 |
2.228200E-01 |
|
|
